Leadership and Selection Panel

President

Vice President Selection Panel

Selection Panel

All companies joining the Tech Tour AI for Health 2025 programme will be selected by the Selection Panel. This Selection Panel is responsible for nominating companies and will select the best 40 companies to take part in the programme. 

Roberto Ascione

President, Health Innovation

EVERSANA (United States)

prevention

Paul Ashley

Director, External Innovation, Data Science and Digital Health

Johnson & Johnson Innovation (United Kingdom)

Virtual care

Drug discovery

prevention

Pedro Castel-Branco

Armilar Venture Partners (Portugal)

Virtual care

Mathieu Chaffard

Roche Diagnostics International (Switzerland)

Virtual care

Drug discovery

prevention

Tony Chang

Senior Business Developer

BioInnovation Institute Fonden (Denmark)

Drug discovery

Seda Cinhuseyinoglu Bog

Head of Strategy and Business Development

Koc Yasa Cok Yasa Medikal (Turkiye)

Virtual care

prevention

Fabrizio Conicella

head Open Innovation & Competence

Chiesi Farmaceutici (Italy)

Virtual care

Antoine D'Hollander

Investment Manager

Capricorn Partners (Belgium)

Virtual care

prevention

Coenraad Davidsdochter

Senior Consultant

Qserve Group (Netherlands)

Virtual care

prevention

Fredrik Debong

CCO and a few more

Onetwenty.ai (Switzerland)

Drug discovery

Jana Drechsler

Project Management Healthcare

EWG - Essener Wirtschaftsförderung (Germany)

Virtual care

Marina Du

Associate Investor

Hitachi Ventures (Germany)

Drug discovery

prevention

Jan Engels

Investment Manager

High-Tech Gruenderfonds (HTGF) (Germany)

Virtual care

Drug discovery

prevention

Raphael Faessler

Investment Director

Swiss Post Ventures (Switzerland)

Virtual care

prevention

David Farquhar

CEO

Intelligent Growth Solutions (United Kingdom)

Virtual care

Tatum Getty

THENA Capital (United Kingdom)

Virtual care

Nicolas Guggenheim

Independent Board Member and Strategic Investor in Healthcare

- (Switzerland)

Virtual care

Philipp Harnischfeger

Arve Capital (Germany)

Virtual care

Tyler Hayes

Principal

Thuja Capital (Netherlands)

Drug discovery

Mario Huyghe

Senior Venture Development Manager

imec (Belgium)

Virtual care

prevention

Juho Immonen

Data Scientist

Bayer (Germany)

Drug discovery

prevention

Jan Jeske

Principal

Neoteq ventures (Germany)

Virtual care

Alper Karagoz

Partner

Diffusion Capital Partners (DCP) (Turkiye)

Virtual care

Drug discovery

prevention

Bernard Kirsch

Angels Santé (France, Metropolitan)

prevention

Philipp Kopp

Investment Manager

bmp Ventures (Germany)

Drug discovery

prevention

Lauri Kuronen

CEO, Denmark unit

LKP-Invest (Finland)

Virtual care

Philippa Köhnk

BRYCK (Germany)

prevention

Nicolas Lagreze

WeBuild Ventures (Switzerland)

Virtual care

prevention

Ari-Pekka Laitsaari

Growth Capital and Innovation Finance

European Investment Bank (Luxembourg)

prevention

Steven Leuridan

Partner

Qbic (Belgium)

Virtual care

Drug discovery

prevention

Amine MAROUF

Kurma Partners (France)

Virtual care

Drug discovery

prevention

Marco Mohwinckel

Tech Tour Advisor

Magnolia Health Advisors (United Kingdom)

Virtual care

Drug discovery

prevention

Antonio Murta

Managing Director

Pathena (Portugal)

Virtual care

prevention

Erki Mölder

Managing Partner

Verge Capital Management (Singapore)

Virtual care

prevention

Nicolas Olberg

IT Investor & Managing Director

Twip Impact Ventures (Germany)

Virtual care

Xavier Pardo

Managing Director

Xerpa (Switzerland)

prevention

Aishwarya Parthasarathy

Investment Analyst

Sofinnova Partners (France)

Drug discovery

prevention

Lennig Pedron

CEO

Trust Valley (Switzerland)

Drug discovery

prevention

Kustaa Piha

CEO and Investor in Healthcare and Medtech

Athensmed Oy (Finland)

Virtual care

Drug discovery

prevention

Rocio Pillado

Partner

Adara Venture Partners (Spain)

Virtual care

prevention

Esther Richardot Reynal De Saint-Michel

THENA Capital (United Kingdom)

Virtual care

Dietmar Schlößer

Director Digitalization & Innovation

TÜV NORD GROUP (Germany)

Virtual care

Maria Severina

CEO, Angel Investor

Almaral (Finland)

Virtual care

prevention

Remi Spagnol

Investments Healthcare

Supernova Invest (France)

Virtual care

Drug discovery

prevention

Christian Stephan

Managing Director

KAIROS - an IQVIA business (Germany)

prevention

Aleksandar Terziyski

Partner

NV3 Fund (Bulgaria)

Virtual care

Sophia Tran

Founder & CEO

Spotlight! Ventures (Germany)

Virtual care

Ralph BMH van Aken

CEO & Owner

Wolf Nose (Netherlands)

Virtual care

prevention

Katleen Vandersmissen

HERAN Partners (Belgium)

Drug discovery

Beatriz Volckaert

Investment Director - Philips Ventures

Philips Ventures (Netherlands)

Virtual care

prevention

James Wilson

Vice President

Silverpeak (United Kingdom)

Virtual care